PP612 Use of Rapid Review Methods In Health Technology Assessment For Central Procurement Decisions: Experience In Ukraine

• Published in: International journal of technology assessment in health care 2020-12, Vol.36 (S1), p.44-44
• Main Authors: Piniazhko, Oresta, Rabia, Kachveci, Tetyana, Dumenko, Leleka, Mariya, Masheiko, Alona, Serediuk, Valeriia
• Format: Article
• Language: English
• Subjects: Arthritis; Budgets; Decisions; Government programs; Health technology assessment; Hemophilia; Juvenile rheumatoid arthritis; Medical equipment; Medicine; Oncology; Organizations; Poster Presentations; Procurement; Resource allocation; Rheumatoid arthritis; State budgets; Technology assessment
• ISSN: 0266-4623; 1471-6348
• DOI: 10.1017/S0266462320002056

IntroductionThe Health Technology Assessment (HTA) Department of the “State Expert Center of the Ministry of Health of Ukraine” was established in 2019 for conducting assessments and development of recommendations for informing decisions of the Ukrainian Ministry of Health regarding financing of the health technologies. Since 2015, procurement of medicines by the state budget in Ukraine was carried out through international specialized organizations. The central procurement program covers forty-one programs for different disease areas. The list of medicines and medical devices purchased were based of procurement agreements with specialized organizations approved by Cabinet of Ministers Decree of Ukraine № 255 of 13 March 2019.MethodsDescriptive analysis of methodological processes around rapid review methods in HTA used for the procedure of central procurements of medicines. In the process of conducting rapid assessment we use a modern tool based on the HTA Core Model® for Rapid Relative Effectiveness Assessments version (V3.0). HTA Guidance in Ukraine was developed in 2017.ResultsThe list of government programs, for which rapid review methods in HTAhave been conducted, included following diseases: adult and pediatric oncology, juvenile rheumatoid arthritis, hemophilia, and orphan diseases. Reports include an overview of comparative efficacy, effectiveness and safety, as well as analysis of reports from HTA agencies and thresholds, budget impact for informing decisions for development of the central procurement programs in 2019. The HTA Department conducted more than forty reviews in less than 6 months.ConclusionsUse of rapid review methods in HTA in Ukraine for informing decisions for the central procurement programs of medicines is the perspective for rational resource allocation and spending. This increases and improves patients’ access to effective, safe and cost-effective medicines.